메뉴 건너뛰기




Volumn 12, Issue 5, 2003, Pages 473-480

Prevention and treatment of osteoporosis in primary care offices

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALUMINUM DERIVATIVE; ANTACID AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CORTICOSTEROID; ESTROGEN DERIVATIVE; ETIDRONIC ACID; PROGESTERONE DERIVATIVE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THYROID HORMONE; VITAMIN D;

EID: 0037622702     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099903766651595     Document Type: Review
Times cited : (14)

References (23)
  • 1
    • 0032477268 scopus 로고    scopus 로고
    • Primary prevention of postmenopausal osteoporosis
    • Levinson W, Altkorn D. Primary prevention of postmenopausal osteoporosis. JAMA 1998;280:1821.
    • (1998) JAMA , vol.280 , pp. 1821
    • Levinson, W.1    Altkorn, D.2
  • 3
    • 0030763532 scopus 로고    scopus 로고
    • Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
    • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670.
    • (1997) N. Engl. J. Med. , vol.337 , pp. 670
    • Dawson-Hughes, B.1    Harris, S.S.2    Krall, E.A.3    Dallal, G.E.4
  • 4
    • 0028032179 scopus 로고
    • Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss
    • Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 1994;120:97.
    • (1994) Ann. Intern. Med. , vol.120 , pp. 97
    • Aloia, J.F.1    Vaswani, A.2    Yeh, J.K.3    Ross, P.L.4    Flaster, E.5    Dilmanian, F.A.6
  • 6
    • 0021964389 scopus 로고
    • Long-term estrogen replacement therapy prevents bone loss and fractures
    • Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319.
    • (1985) Ann. Intern. Med. , vol.102 , pp. 319
    • Ettinger, B.1    Genant, H.K.2    Cann, C.E.3
  • 9
    • 0019208916 scopus 로고
    • Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
    • Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195.
    • (1980) N. Engl. J. Med. , vol.303 , pp. 1195
    • Weiss, N.S.1    Ure, C.L.2    Ballard, J.H.3    Williams, A.R.4    Daling, J.R.5
  • 10
    • 0018655759 scopus 로고
    • Postmenopausal oestrogens protect against fractures of hip and distal radius. A case-control study
    • Hutchinson TA, Polansky SM, Feinstein AR. Postmenopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet 1979;2:705.
    • (1979) Lancet , vol.2 , pp. 705
    • Hutchinson, T.A.1    Polansky, S.M.2    Feinstein, A.R.3
  • 11
    • 0346344235 scopus 로고    scopus 로고
    • Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
    • Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338:485.
    • (1998) N. Engl. J. Med. , vol.338 , pp. 485
    • Hosking, D.1    Chilvers, C.E.2    Christiansen, C.3
  • 12
    • 6844266291 scopus 로고    scopus 로고
    • Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial
    • McClung M, Clemmesen B, Daifotis A, et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Ann Intern Med 1998;128:253.
    • (1998) Ann. Intern. Med. , vol.128 , pp. 253
    • McClung, M.1    Clemmesen, B.2    Daifotis, A.3
  • 13
    • 0035253489 scopus 로고    scopus 로고
    • Effect of risedronate on the risk of hip fracture in elderly women
    • McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333.
    • (2001) N. Engl. J. Med. , vol.344 , pp. 333
    • McClung, M.R.1    Geusens, P.2    Miller, P.D.3
  • 14
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    • Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535.
    • (1996) Lancet , vol.348 , pp. 1535
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 15
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial
    • Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA 1999;282:1344.
    • (1999) JAMA , vol.282 , pp. 1344
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3
  • 16
    • 12944291524 scopus 로고    scopus 로고
    • Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    • Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83.
    • (2000) Osteoporos. Int. , vol.11 , pp. 83
    • Reginster, J.1    Minne, H.W.2    Sorensen, O.H.3
  • 17
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    • Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637.
    • (1999) JAMA , vol.282 , pp. 637
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 18
    • 0026691295 scopus 로고
    • Treatment of postmenopausal osteoporosis with transdermal estrogen
    • Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.
    • (1992) Ann. Intern. Med. , vol.117 , pp. 1-9
    • Lufkin, E.G.1    Wahner, H.W.2    O'Fallon, W.M.3
  • 19
    • 0034028980 scopus 로고    scopus 로고
    • Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide
    • Heinemann DF. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. Geriatrics 2000;55:31.
    • (2000) Geriatrics , vol.55 , pp. 31
    • Heinemann, D.F.1
  • 20
    • 0003536740 scopus 로고    scopus 로고
    • U.S. Preventive Service Task Force. 2nd ed. Baltimore: Williams & Wilkins
    • U.S. Preventive Service Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996.
    • (1996) Guide to Clinical Preventive Services
  • 21
    • 85039664835 scopus 로고
    • Logician 4.6. 4.6 ed. Hillsboro: MedicaLogic/Medscape, Inc
    • Logician 4.6. 4.6 ed. Hillsboro: MedicaLogic/Medscape, Inc., 1994.
    • (1994)
  • 22
    • 0035852034 scopus 로고    scopus 로고
    • Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment
    • Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815.
    • (2001) JAMA , vol.286 , pp. 2815
    • Siris, E.S.1    Miller, P.D.2    Barrett-Connor, E.3
  • 23
    • 0035348890 scopus 로고    scopus 로고
    • Impact of an electronic medical record on quality of care in a primary care office
    • Gill JM, Ewen E, Nserko M. Impact of an electronic medical record on quality of care in a primary care office. Del Med J 2001;73:187.
    • (2001) Del. Med. J. , vol.73 , pp. 187
    • Gill, J.M.1    Ewen, E.2    Nserko, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.